Sit Investment Associates’s BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. DCF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,639,141
Closed -$15M 557
2024
Q3
$15M Buy
1,639,141
+298,004
+22% +$2.68M 0.34% 85
2024
Q2
$11.9M Buy
1,341,137
+43,496
+3% +$375K 0.27% 106
2024
Q1
$11.2M Buy
1,297,641
+100,706
+8% +$849K 0.26% 114
2023
Q4
$9.76M Buy
1,196,935
+437,544
+58% +$3.43M 0.24% 125
2023
Q3
$5.89M Buy
759,391
+276,691
+57% +$2.14M 0.16% 178
2023
Q2
$3.64M Buy
482,700
+50,551
+12% +$384K 0.1% 225
2023
Q1
$3.28M Buy
432,149
+237,499
+122% +$1.79M 0.09% 240
2022
Q4
$1.37M Buy
194,650
+157,000
+417% +$1.13M 0.04% 330
2022
Q3
$257K Buy
+37,650
New +$277K 0.01% 433

Sit Investment Associates's DCF Position: Q4 2024 in Review

Sit Investment Associates sold out of BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (DCF) in Q4 2024, closing a stake of 1,639,141 shares — an estimated $15M sold.

Sit Investment Associates first reported a position in DCF in Q3 2022 and held it in 9 quarters. The position peaked at $15M in Q3 2024. 0 funds tracked by Wall St. Rank hold DCF as of Q4 2024.

  • Sit Investment Associates reported no remaining BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. position as of Q4 2024 after selling out during the quarter.
  • Sit Investment Associates sold 1,639,141 BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. shares in Q4 2024, an estimated $15M.
  • Sit Investment Associates first reported a position in BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. in Q3 2022 and held it in 9 quarters.
  • Sit Investment Associates's BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. position peaked at $15M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. as of Q4 2024.

Based on Sit Investment Associates's 13F filing for Q4 2024, filed 13 Feb 2025.